Why the study?
This study aims to analyze the impact of the Hospital Readmissions Reduction Program on nationwide optimization efforts for length of stay and readmissions in the United States.
Does the Hospital Readmissions Reduction Program (HRRP) reduce readmission rates and length of stay for targeted conditions compared to non-targeted conditions?
Population
Patients with AMI, COPD, CHF, pneumonia, septicemia, or mood disorders in the Nationwide Readmission Database
Comparison
HRRP-monitored conditions vs non-monitored conditions (septicemia and mood disorders)
Design
Retrospective database study
Loading...
CHF readmissions remain highest for Medicaid patients; leaves open HRRP causality versus secular trends after heterogeneity adjustment.
Does the Hospital Readmissions Reduction Program (HRRP) reduce readmission rates and length of stay for targeted conditions compared to non-targeted conditions?
Targeted programs like HRRP may positively impact readmission rates, though non-targeted conditions exhibited similar trends, emphasizing the need to account for hospital and patient heterogeneity.
A 2021 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: